ALK-Abelló A/S
AKBLFOTCHealthcare● Active
$31.35
$-7.54(-19.39%)
Market Cap$6.3B
P/E Ratio—
52W High$38.89
52W Low$26.99
ALK-Abelló A/S (AKBLF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AKBLF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 4, 2026EPS Actual
$0.31
Est. $0.26 · +17.7%
Revenue
$0.27B
Est. $0.26B · +3.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 4, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
AKBLF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 20, 2026 | $0.23 | — | — | — | $0.27B | — |
| ▲ Q2 FY2026 | May 4, 2026 | $0.26 | $0.31 | +17.7% | $0.27B | $0.26B | +3.3% |
| ▼ Q1 FY2026 | Feb 20, 2026 | $0.20 | $0.19 | -7.7% | $0.27B | $0.27B | +1.6% |
| ▲ Q4 FY2025 | Nov 12, 2025 | $0.16 | $0.22 | +40.2% | $0.24B | $0.27B | -10.1% |
| ▼ Q3 FY2025 | Aug 21, 2025 | $0.20 | $0.19 | -7.6% | $0.24B | $0.23B | +5.7% |
| ▲ Q2 FY2025 | May 6, 2025 | $0.20 | $0.24 | +20.4% | $0.22B | $0.23B | -1.1% |
| ▼ Q1 FY2025 | Feb 19, 2025 | $0.14 | $0.11 | -22.1% | $0.21B | $0.21B | -0.4% |
| ▲ Q4 FY2024 | Nov 14, 2024 | $0.12 | $1.00 | +744.6% | $0.19B | $0.22B | -10.8% |
Q3 FY2026
Aug 20, 2026
EPS Actual
—
EPS Est.
$0.23
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 4, 2026Beat
EPS Actual
$0.31
EPS Est.
$0.26
EPS Surpr.
+17.7%
Revenue
$0.27B
Q1 FY2026
Feb 20, 2026Miss
EPS Actual
$0.19
EPS Est.
$0.20
EPS Surpr.
-7.7%
Revenue
$0.27B
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
$0.22
EPS Est.
$0.16
EPS Surpr.
+40.2%
Revenue
$0.24B
Q3 FY2025
Aug 21, 2025Miss
EPS Actual
$0.19
EPS Est.
$0.20
EPS Surpr.
-7.6%
Revenue
$0.24B
Q2 FY2025
May 6, 2025Beat
EPS Actual
$0.24
EPS Est.
$0.20
EPS Surpr.
+20.4%
Revenue
$0.22B
Q1 FY2025
Feb 19, 2025Miss
EPS Actual
$0.11
EPS Est.
$0.14
EPS Surpr.
-22.1%
Revenue
$0.21B
Q4 FY2024
Nov 14, 2024Beat
EPS Actual
$1.00
EPS Est.
$0.12
EPS Surpr.
+744.6%
Revenue
$0.19B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $1.38 | $1.41 | $1.44 | 1 |
| Q3 FY2026 | $1.47 | $1.51 | $1.54 | 1 |
| Q2 FY2026 | $1.47 | $1.51 | $1.54 | 1 |
| Q1 FY2026 | $1.66 | $1.70 | $1.74 | 1 |
| Q4 FY2025 | $1.27 | $1.30 | $1.33 | 1 |
| Q3 FY2025 | $0.99 | $1.00 | $1.00 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $2.0B | $2.0B | $2.1B | 1 |
| Q3 FY2026 | $1.7B | $1.7B | $1.8B | 2 |
| Q2 FY2026 | $1.7B | $1.7B | $1.8B | 2 |
| Q1 FY2026 | $1.7B | $1.7B | $1.7B | 4 |
| Q4 FY2025 | $1.7B | $1.7B | $1.7B | 2 |
| Q3 FY2025 | $1.5B | $1.5B | $1.5B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 4, 2026 | +17.7% | $35.55 | $35.55 | +0.00% |
| ▼ Q1 FY2026 | Feb 20, 2026 | -7.7% | $36.10 | $36.10 | +0.00% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +40.2% | $33.00 | $33.05 | +0.15% |
| ▼ Q3 FY2025 | Aug 21, 2025 | -7.6% | $28.95 | $28.95 | +0.00% |
| ▲ Q2 FY2025 | May 6, 2025 | +20.4% | $19.90 | $25.95 | +30.40% |
| ▼ Q1 FY2025 | Feb 19, 2025 | -22.1% | $21.35 | $21.35 | +0.00% |
| ▲ Q4 FY2024 | Nov 14, 2024 | +744.6% | $23.80 | $22.60 | -5.04% |
| ▲ Q3 FY2024 | Aug 23, 2024 | +44.4% | $21.68 | $21.68 | +0.00% |
Q2 FY2026+0.00%
Report Date
May 4, 2026
EPS Beat/Miss
+17.7%
Price Before
$35.55
Price After
$35.55
Q1 FY2026+0.00%
Report Date
Feb 20, 2026
EPS Beat/Miss
-7.7%
Price Before
$36.10
Price After
$36.10
Q4 FY2025+0.15%
Report Date
Nov 12, 2025
EPS Beat/Miss
+40.2%
Price Before
$33.00
Price After
$33.05
Q3 FY2025+0.00%
Report Date
Aug 21, 2025
EPS Beat/Miss
-7.6%
Price Before
$28.95
Price After
$28.95
Q2 FY2025+30.40%
Report Date
May 6, 2025
EPS Beat/Miss
+20.4%
Price Before
$19.90
Price After
$25.95
Q1 FY2025+0.00%
Report Date
Feb 19, 2025
EPS Beat/Miss
-22.1%
Price Before
$21.35
Price After
$21.35
Q4 FY2024-5.04%
Report Date
Nov 14, 2024
EPS Beat/Miss
+744.6%
Price Before
$23.80
Price After
$22.60
Q3 FY2024+0.00%
Report Date
Aug 23, 2024
EPS Beat/Miss
+44.4%
Price Before
$21.68
Price After
$21.68
Avg Beat Reaction+5.10%
Avg Miss Reaction+0.00%
Beat Rate5 / 8 quarters
Largest Move+30.40% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AKBLF ends December
ALK-Abelló A/S (AKBLF) most recently reported earnings on May 4, 2026 for Q2 FY2026, posting EPS of $0.31 — beating the analyst consensus of $0.26 by +17.7%. The next AKBLF earnings date is expected around September 1, 2026.
Each quarter, investors track AKBLF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AKBLF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AKBLF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AKBLF earnings · 5 questionsALK-Abelló A/S's next earnings report is expected around September 1, 2026. AKBLF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AKBLF historically reports after market close (AMC).
AKBLF earnings datewhen is AKBLF earningsAKBLF next earnings datewhen does AKBLF report earningsAKBLF earnings calendar
▸ Source: FMP · ALK-Abelló A/S SEC filings · US GAAP · ALK-Abelló A/S SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026